Synagis (palivizumab) is a monoclonal antibody indicated to prevent a severe lower respiratory tract disease caused by RSV in infants and children at high risk
[DOI] [PMC free article] [PubMed] [Google Scholar] 119.Lou M.F
J Biol Chem 285:3632236329
Back to Journals Diabetes, Metabolic Syndrome and Obesity Volume 16 GLP-1RA Liraglutide and Semaglutide Improves Obesity-Induced Muscle Atrophy via SIRT1 Pathway Authors Xiang J , Qin L , Zhong J, Xia N , Liang Y Received 12 June 2023 Accepted for publication 5 August 2023 Published 15 August 2023 Volume 2023:16 Pages 24332446 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Konstantinos Tziomalos Jie Xiang, 1 Liyan Qin, 2 Jinling Zhong, 3 Ning Xia, 2 Yuzhen Liang 3 1 Department of Clinical Nutrition, The First Affiliated Hospital of Guangxi Medical University, Nanning, Peoples Republic of China
Jan 27, 2026 You have been injecting peptides for months
Strategic intent : This investment highlights OneSources plan to establish a strong early foothold in the growing weight-loss generics segment
